<DOC>
	<DOCNO>NCT02591888</DOCNO>
	<brief_summary>Liposomal bupivacaine placebo administer end transobturator midurethral sling determine difference patient 's perceived postoperative pain .</brief_summary>
	<brief_title>Impact Liposomal Bupivacaine Administered Following Placement Transobturator Suburethral Sling</brief_title>
	<detailed_description>The investigator aim evaluate use liposomal bupivacaine reduce postoperative pain placement transobturator sling treatment stress urinary incontinence .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Adults &gt; 18 year age Planning outpatient surgical treatment SUI placement transobturator suburethral sling general anesthesia Pregnant nursing Allergy bupivacaine History drug/alcohol abuse Severe cardiovascular , hepatic , renal disease , neurological impairmentÂ° Longacting opioid within 3 day opioid use within 24 hour surgery Contraindication : acetaminophen oxycodone nonsteroidal antiinflammatory drug ( NSAID ) Administration investigational drug within 30 day study Chronic pain syndrome Daily NSAID/opioid use Patients concomitant procedure undergo general anesthesia Patients require concomitant anterior repair urethrocele repair exclude require dissection anterior vaginal wall .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>